PYRIDOSTIGMINE BROMIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for pyridostigmine bromide and what is the scope of freedom to operate?
Pyridostigmine bromide
is the generic ingredient in three branded drugs marketed by Bausch, Sandoz, Amneal, Milla Pharms, MSN, Novitium Pharma, Rising, Alvogen, Impax Labs Inc, Ani Pharms, Impax Labs, MLV, Solvay, Us Army, and Zydus Pharms, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.There are eleven drug master file entries for pyridostigmine bromide. Twenty-two suppliers are listed for this compound.
Summary for PYRIDOSTIGMINE BROMIDE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 15 |
NDAs: | 20 |
Drug Master File Entries: | 11 |
Finished Product Suppliers / Packagers: | 22 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Clinical Trials: | 21 |
Patent Applications: | 1,899 |
What excipients (inactive ingredients) are in PYRIDOSTIGMINE BROMIDE? | PYRIDOSTIGMINE BROMIDE excipients list |
DailyMed Link: | PYRIDOSTIGMINE BROMIDE at DailyMed |
Recent Clinical Trials for PYRIDOSTIGMINE BROMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Vermont Medical Center | Phase 2 |
Stefan Holubar MD MS FACS, FASCRS | Phase 2/Phase 3 |
Michael E. DeBakey VA Medical Center | Early Phase 1 |
Pharmacology for PYRIDOSTIGMINE BROMIDE
Drug Class | Cholinesterase Inhibitor |
Mechanism of Action | Cholinesterase Inhibitors |
Medical Subject Heading (MeSH) Categories for PYRIDOSTIGMINE BROMIDE
Anatomical Therapeutic Chemical (ATC) Classes for PYRIDOSTIGMINE BROMIDE
US Patents and Regulatory Information for PYRIDOSTIGMINE BROMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Impax Labs | PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | TABLET;ORAL | 040502-001 | Apr 24, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Msn | PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | SYRUP;ORAL | 216512-001 | Sep 21, 2023 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sandoz | REGONOL | pyridostigmine bromide | INJECTABLE;INJECTION | 017398-001 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Impax Labs | PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | TABLET;ORAL | 040502-002 | Jun 28, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bausch | MESTINON | pyridostigmine bromide | SYRUP;ORAL | 015193-001 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Alvogen | PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | TABLET, EXTENDED RELEASE;ORAL | 204737-001 | Jun 26, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Solvay | PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | TABLET;ORAL | 089572-001 | Nov 27, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.